Burden of MASLD and liver fibrosis: evidence from Phenome India cohort

Read full text
Authors: Meghana Arvind, Anshul Verma, Sreeshma Raj K, Satyartha Prakash, Vignesh S Kumar, Mohammad Ahsan Uddin, A. V. Narayan, Mamta Rathore, Nancy Rawat, Ankita Sahu, Yogesh Kumar, Pulkit Hasmukhbhai Leuva
+88 more Monika Sharma, Rajesh S, Dwaipayan Saha, Ankita Mridha, Ishant Jyoti Nath, Ashique Hussain, Borsha Rajkumari, Mamta Thapa, Neha Kumari, Vishwapriya S, Shilpak Chatterjee, Dipyaman Ganguly, Ashish Awasthi, V.K. Yenamandra, Ajay Pratap Singh, Aastha Mishra, Swasti Raychaudhuri, Karthik Bharadwaj Tallapaka, Giriraj R. Chandak, Mahesh J. Kulkarni, Mahesh Dharne, Romi Wahengbam, Umakanta Subudhi, Sagnik Biswas, Shalimar, Kumardeep Chaudhary, Shantanu Sengupta, Partha Chakrabarti, Viren Sardana, Abhishek Kumar, Ankit Basnal, Ankur Halder, Anshul Bhardwaj, Ansuman Sahu, Bharti Sharma, Debasis Dash, Deeksha Yadav, Deepak, Kalyani Verma, Komal Jindal, Md. Intyaz Ali, Mohit, Pankaj Pandey, Pranjal Tewari, Pratik Pathade, Praveena Mishra, Rohit Kumar, Ruchi, Safeer Khan, Shail Kumari, Shilpa Ray, Shivani Chitkara, Shubham Kumar, Shyam Singh Bisht, Sumant Kumar, Swarnendu Bag, Swati, Tanmay Pawaskar, Tarani Mathur, Vivek Junghare, Dipamoy Dutta, Md Jahangir Alam, P S Basu, Saheli Chowdhury, Saikat Majumder, Dibya Rana Saha Roy, Jukanti Akshitha, M.K. Kanakavalli, Rakhesh Kv, Ajit A Sutar, Ameya A. Pawar, Ankita Namdeo, Apurva Balge, Ashok P. Giri, Chiranjit Chowdhury, Dhanasekaran Shanmugam, Milind Kale, Narendra Y. Kadoo, Nikhilesh Yadav, Rashdajabeen Q Shaikh, Sagar Baulia, Shivani V. Palkar, Shrutika M. Shewale, Shyam K. Gawari, Syed G. Dastager, Vaishnavi N. Mahajan, Bhabani Sankar Jena, Boopathy Ramasamy
Cited by: 5
References: 37

Abstract

Background: Metabolic-dysfunction-associated steatotic liver disease (MASLD) is rising globally, including in India, yet community-based data remain scarce. We address this critical knowledge gap by assessing the prevalence, distribution, and characteristics of MASLD subgroups and fibrosis, leveraging the Phenome India cohort. Methods: In this prospective study, we recruited 10,267 adults across 37 laboratories of the Council of Scientific and Industrial Research (CSIR) from 27 Indian cities. All permanent staff members of the CSIR, including current employees, retirees, and their spouses who responded to the recruitment campaign and provided voluntary consent, were considered for participation in the Phenome India Cohort. Steatosis and fibrosis were assessed using Transient Elastography, along with associated clinical, biochemical, cytokine and anthropometric data. Overall, crude and age-adjusted prevalence rates were estimated in the study population and various subgroups. Findings: Of 10,267 individuals screened, 7764 were included, 3712 (47.8%) fulfilled MASLD criteria, corresponding to an age-adjusted prevalence of 38.9% (95% CI 37.2-40.6). Significant fibrosis, defined as liver stiffness measurement (LSM) ≥8.2 kPa (≥F2), was more frequent in MASLD (6.3% [234 of 3688]) than in cases without-MASLD (1.7% [69 of 4027]), corresponding to an age-adjusted prevalence of 4.1% in MASLD. Overall age-adjusted prevalence of significant fibrosis was 2.4%, which clustered in older adults (>60 years) and in those with diabetes or obesity class II, with evidence of possible regional variation. Interpretation: MASLD affected over one-third of participants. Site-specific disparities were observed, which suggest the need for large-scale longitudinal studies to elucidate region-specific risk factors and temporal trends. Community-based awareness and targeted public health interventions across diverse geographical and socio-cultural settings in India may help curb the rising burden. Funding: The work was funded by CSIR, India grant HCP47.

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Liver Disease and Transplantation Liver Diseases and Immunity

Publication details

Journal / source
The Lancet Regional Health - Southeast Asia
Publisher
Elsevier BV
Volume
45
Pages
100723–100723
Publication date
1 February 2026
Language
EN